drugset / Trial / NCT00136474
Amifostine for Head and Neck Irradiation in Lymphoma
Phase 2
Completed
75 enrolled
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center · collabBrigham and Women's Hospital · collabMedImmune LLC · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is determine the effects (good and bad) amifostine has on radiation-induced side effects of lymphoma treatment.
Timeline
- Start
- 2003-05
- Primary completion
- 2005-05
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | amifostine | Unknown | — | Other |